07/09/2021 15:36
ClarĂn.com
Society
Updated 07/09/2021 3:39 PM
The official Twitter account of the Russian anticovid vaccine Sputnik V released an article this Friday morning in which the Reuters news agency attributes to the Russian Direct Investment Fund (RDIF) the statement that
the interval between doses of the Sputnik V can be extended for up to 180 days
and "will remain effective."
The Reuters article, which cites the case of Argentina, immediately details: "An official of the RDIF, which markets the vaccine abroad, made the comments in a statement after some countries decided to
widen the gap between the first and the second. second dose
of the vaccine developed in Russia ".
The RDIF official cited trials from the Gamaleya Center showing that longer gaps had ensured
a better immune response
.
However, it did not provide details of those trials.
Reuters: Russian Sovereign Wealth Fund RDIF says, citing Sputnik V developer, that interval between two doses can be extended to 180 days in some countries
👇https: //t.co/Rz4a33KxGo
- Sputnik V (@sputnikvaccine) July 9, 2021
The statement about the longest deadline to receive the second dose of Sputnik V was issued by the RDIF official at a request from Reuters.
And he denied that his comment was
in any way related to
Russian
deliveries
of the vaccine.
Alexander Gintsburg, director of the Gamaleya Center, which developed the vaccine, had said in April this year that the interval between applications
could be extended to 90 days
.
This novelty had special relevance in Argentina, in particular for the large number of older adults who had received component 1 of Sputnik V and were learning of the
delays in the arrival of the second component
.
Until then, the recommendation was to separate the doses 21 days and no more than 60 days.
"It is possible to increase the minimum interval between the first and second vaccines, from the 21 days previously approved to
three months,
" the Gamaleya Center said in a statement on Monday, April 26.
That text ensured that the extension of the interval would not affect the vaccine, and added that, in some cases, it could
enhance it and prolong its effect
.
However, at that time, precise data on the research supporting the new suggested interval had not been released.
Now, the news of a possible
new extension to 180 days
of the effective interval between doses of the Russian vaccine comes with even less detail.
Before
ClarĂn's
query
, the local representatives of the Russian Direct Investment Fund sent the tweet issued by the official account of Sputnik V.
There, in English, next to the link to the Reuters article, you can read: "Reuters: Russia's Sovereign Fund RDIF says, citing a Sputnik V developer, that the interval between two doses can be extended to 180 days in some countries ".
LGP
Look also
An Oxford study ensures that a long interval between the two doses of the AstraZeneca vaccine improves its effectiveness
Fernán Quirós, on the possibility of combining vaccines: "They must have at least one evaluation of safety and efficacy"